EUVIMEDEUVIMED entdecken
Crossref

Growth hormone therapy is associated with improved uterine dimensions in girls with Turner syndrome prior to oestrogen replacement

Sunetra Mondal iD, Piyas Gargari, Lakshmi Nagendra, Santanu Mandal, Rathin C Kumar, Pooja Shah, Mandira Haldar, Subhankar Chowdhury, Satinath Mukhopadhyay

Clinical Endocrinology · 2024

DOI: 10.1111/cen.14957 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Endocrinology, 2024. Verfasst von Sunetra Mondal und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Institute of Post Graduate Medical Education and Research, Kolkata, West Bengal, India. Hauptthemen laut MEDLINE: Human Growth Hormone, Turner Syndrome. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Adult women with Turner syndrome (TS) have high rates of miscarriage, presumably due to the abnormal size and shape of the uterus. There is a paucity of data regarding the determinants of uterine volume (UtVol) in young girls with TS before the initiation of oestrogen replacement therapy (ERT).

Methods

We performed a cross‐sectional study on premenarchal girls with TS, aged 5–15 years, pubertal stage B1–B3, not having received ERT ( n = 73) and 50 age‐matched healthy controls. Anthropometric parameters and a history of growth hormone (GH) therapy (≥1 year) were noted. Uterine length (UtL), UtVol, and mean‐ovarian‐volume (MOV) standard‐deviation scores (SDS) were determined from transabdominal ultrasonography data.

Results

Girls with TS had lower median UtVol‐SDS (−1.07 vs. 0.86; p < .001), UtL‐SDS (−3.72 vs. −0.41; p < .001) and MOV‐SDS (−5.53 vs. 1.96; p < .001) compared to age‐matched controls. Among TS girls, recipients of GH ( n = 38) had higher UtVol‐SDS (−0.63 vs. −1.39; p = .0001), UtL‐SDS (−1.73 vs. −6.49; p < .0001) but similar MOV‐SDS compared to nonrecipients ( n = 35). Those with normal uterine volume for age (NUVA, n = 29) had earlier initiation (7.8 vs. 9.3 years; p = .03) and a longer duration of GH (3.71 vs. 2.14 years; p = .002) than those with low UtVol for age ( n = 44). UtVol‐SDS correlated with duration of GH ( ρ = 0.411, p = .01) and negatively with age at GH initiation ( ρ = −0.479, p = .003). In a model adjusted for pubertal status, karyotype and height‐SDS, GH use could independently predict having NUVA (odds ratio: 5.09, confidence interval: 1.63–15.94, p = .005).

Conclusion

GH therapy has a stimulatory effect on uterine dimensions in pre‐and peripubertal girls with TS. Earlier initiation and longer duration of GH is important in TS girls before ERT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Human Growth HormoneTurner SyndromeFemaleHumansBody HeightCross-Sectional StudiesEstrogen Replacement TherapyGrowth HormoneUterusChild, PreschoolChildAdolescent

Stichwörter der Autor:innen

Turner syndromegrowth hormoneovarian volumeuterine lengthuterine volume

Substanzen

Growth HormoneHuman Growth Hormone

Autor:innen und Institutionen

  • Department of Endocrinology, Institute of Post Graduate Medical Education and Research, Kolkata, West Bengal, India.
  • Department of Endocrinology, JSS Medical College and Hospital, JSS Academy of Higher Education and Research, Mysore, Karnataka, India.
  • Department of Radiology, Institute of Post Graduate Medical Education and Research, Kolkata, West Bengal, India.
  • Healthworld Hospitals, Durgapur, West Bengal, India.

ORCID-Profile: Sunetra Mondal

Zitieren

APA

Mondal, S., Gargari, P., Nagendra, L., Mandal, S., Kumar, R. C., Shah, P., Haldar, M., Chowdhury, S., & Mukhopadhyay, S. (2024). Growth hormone therapy is associated with improved uterine dimensions in girls with Turner syndrome prior to oestrogen replacement. Clinical Endocrinology. https://doi.org/10.1111/cen.14957

Vancouver

Mondal S, Gargari P, Nagendra L, Mandal S, Kumar RC, Shah P, et al. Growth hormone therapy is associated with improved uterine dimensions in girls with Turner syndrome prior to oestrogen replacement. Clinical Endocrinology. 2024. doi:10.1111/cen.14957

BibTeX
@article{Mondal2024,
  author = {Mondal, Sunetra and Gargari, Piyas and Nagendra, Lakshmi and Mandal, Santanu and Kumar, Rathin C and Shah, Pooja and Haldar, Mandira and Chowdhury, Subhankar and Mukhopadhyay, Satinath},
  title = {Growth hormone therapy is associated with improved uterine dimensions in girls with Turner syndrome prior to oestrogen replacement},
  journal = {Clinical Endocrinology},
  year = {2024},
  doi = {10.1111/cen.14957}
}
Kostenlos starten →